1-113768335-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_018364.5(RSBN1):c.1713C>T(p.Arg571=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000499 in 1,612,394 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 2 hom. )
Consequence
RSBN1
NM_018364.5 synonymous
NM_018364.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.33
Genes affected
RSBN1 (HGNC:25642): (round spermatid basic protein 1) Predicted to enable dioxygenase activity and metal ion binding activity. Predicted to be involved in chromatin organization. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-113768335-G-A is Benign according to our data. Variant chr1-113768335-G-A is described in ClinVar as [Benign]. Clinvar id is 791807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.33 with no splicing effect.
BS2
High AC in GnomAd4 at 416 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RSBN1 | NM_018364.5 | c.1713C>T | p.Arg571= | synonymous_variant | 5/7 | ENST00000261441.9 | |
RSBN1 | NR_130896.2 | n.1895C>T | non_coding_transcript_exon_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RSBN1 | ENST00000261441.9 | c.1713C>T | p.Arg571= | synonymous_variant | 5/7 | 2 | NM_018364.5 | P1 | |
RSBN1 | ENST00000612242.4 | c.1713C>T | p.Arg571= | synonymous_variant | 5/7 | 2 | P1 | ||
RSBN1 | ENST00000615321.1 | c.1569C>T | p.Arg523= | synonymous_variant | 5/7 | 2 | |||
RSBN1 | ENST00000476412.5 | c.*451C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00275 AC: 418AN: 152058Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
418
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000753 AC: 189AN: 250932Hom.: 1 AF XY: 0.000582 AC XY: 79AN XY: 135662
GnomAD3 exomes
AF:
AC:
189
AN:
250932
Hom.:
AF XY:
AC XY:
79
AN XY:
135662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000266 AC: 389AN: 1460218Hom.: 2 Cov.: 30 AF XY: 0.000224 AC XY: 163AN XY: 726500
GnomAD4 exome
AF:
AC:
389
AN:
1460218
Hom.:
Cov.:
30
AF XY:
AC XY:
163
AN XY:
726500
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00273 AC: 416AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00263 AC XY: 196AN XY: 74396
GnomAD4 genome
AF:
AC:
416
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
196
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at